These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6728740)

  • 21. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guide to oral theophylline therapy for the treatment of chronic asthma.
    Hendeles L; Weinberger M; Wyatt R
    Am J Dis Child; 1978 Sep; 132(9):876-80. PubMed ID: 685905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intersubject variability in plasma theophylline levels after oral and intravenous administration in Jordanian patients with chronic obstructive pulmonary disease.
    Samara N; Sliman N; Sai'd S; Awidi A; Al-Turk W; Othman S; Khalaf R; Shaheen O
    Ther Drug Monit; 1988; 10(2):144-6. PubMed ID: 3381229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theophylline. A "state of the art" review.
    Hendeles L; Weinberger M
    Pharmacotherapy; 1983; 3(1):2-44. PubMed ID: 6344032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition and clinical pharmacokinetics of microcrystalline theophylline.
    Jonkman JH; Berg WC; Schoenmaker R; de Zeeuw RA; Greving JE; Orie NG
    Eur J Clin Pharmacol; 1980 May; 17(5):379-84. PubMed ID: 7418716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.
    Weinberger MW; Matthay RA; Ginchansky EJ; Chidsey CA; Petty TL
    JAMA; 1976 May; 235(19):2110-3. PubMed ID: 946537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualization of theophylline dosage using a single serum sample following a test dose.
    Shapiro GG; Koup JR; Furukawa CT; Pierson WE; Gibaldi M; Fuquay D; Bierman CW
    Pediatrics; 1982 Jan; 69(1):70-3. PubMed ID: 7054763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical pharmacology of theophylline in the treatment of asthma].
    Cuena Boy R; Honorato Pérez JM; Azanza Perea JR
    Rev Med Univ Navarra; 1982 Sep; 26(3):175-80. PubMed ID: 7170535
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children.
    Levy G; Koysooko R
    J Pediatr; 1975 May; 86(5):789-93. PubMed ID: 1133663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
    Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
    J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Individualization of the dosage of oral theophylline with regular increase method and serum level control in 55 asthmatic children (author's transl)].
    Cabanas R; Peña J; Tojo R; Fuster M; Vázquez MC; Cortizo E; Castro-Gago M
    An Esp Pediatr; 1981 Feb; 14(2):89-96. PubMed ID: 7258855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of the mean dose of oral theophylline in asthmatic children (author's transl)].
    Cabanas R; Peña J; Fuster M; Cortizo E; Castro-Gago M; Couselo JM; Tojo R
    An Esp Pediatr; 1982 Feb; 16(2):119-26. PubMed ID: 7081857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and dose regimen of oral theophylline in children.
    Bolme P; Eriksson M; Lönnerholm G; Paalzow L
    Acta Pharmacol Toxicol (Copenh); 1982 Nov; 51(5):401-6. PubMed ID: 7164821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of theophylline; variability and effect of arterial pH in chronic obstructive lung disease.
    Resar RK; Walson PD; Fritz WL; Perry DF; Barbee RA
    Chest; 1979 Jul; 76(1):11-6. PubMed ID: 36261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.
    Jacobs MH; Senior RM; Kessler G
    JAMA; 1976 May; 235(18):1983-6. PubMed ID: 946508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylxanthine therapy and reversible airway obstruction.
    McFadden ER
    Am J Med; 1985 Dec; 79(6A):1-4. PubMed ID: 4083294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.